eastar kang·Just nowEHL BIO: CAR-T Cell Therapy and Its Expanding Clinical FrontierA patient’s own immune cells can now be collected, re-engineered to recognize a defined target, expanded in a controlled setting, and…
CancerFax - Advanced Cancer Treatment·17h agoCAR-T Cell Therapy: Which Cancer Patients Can Actually Benefit?A clear guide for patients and families exploring CAR-T for leukemia, lymphoma, and multiple myeloma
CancerFax - Advanced Cancer Treatment·Sep 30Two Targets Instead of One: What Dual CAR-T Could Change in Blood CancerCAR-T cells have transformed leukemia, lymphoma, and myeloma care. Their biggest weakness is that cancer learns to hide. A new generation…
CancerFax - Advanced Cancer Treatment·Sep 23Inside China’s Race to Treat T-Cell Leukemia: What CD7 CAR-T Therapy Can (and Can’t) Do YetA look at one of oncology’s hardest technical problems, the Chinese research teams solving it, and why the data deserves honest reading…
